Jiangsu, China

Xuejin Zhang

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Chia Tai Tianqing Pharmaceutical Group Go., Ltd.. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xuejin Zhang. Retrieved from https://idiyas.com/inventor/xuejin-zhang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

 

Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Xuejin Zhang: Innovator in Pharmaceutical Chemistry

Introduction

Xuejin Zhang is a prominent inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds for medical applications. His work focuses on innovative solutions for treating serious health conditions.

Latest Patents

Xuejin Zhang holds a patent for an Azetidine derivative. This patent discloses a compound represented by formula (I), along with its pharmaceutically acceptable salts, tautomers, stereoisomers, and geometrical isomers. The compound is particularly noted for its potential uses in the preparation of drugs aimed at treating or preventing multiple myeloma. He has 1 patent to his name.

Career Highlights

Xuejin Zhang is associated with Chia Tai Tianqing Pharmaceutical Group Co., Ltd., where he applies his expertise in drug development. His role in the company has allowed him to contribute to significant advancements in pharmaceutical research and innovation.

Collaborations

Xuejin collaborates with notable colleagues, including Jian Xiong and Cheng Xie. Their combined efforts in research and development have fostered a productive environment for innovation in the pharmaceutical sector.

Conclusion

Xuejin Zhang's work exemplifies the impact of innovative thinking in the pharmaceutical industry. His contributions, particularly in the area of drug development for multiple myeloma, highlight the importance of research and collaboration in advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…